Position in LLY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$9,789,748
+$2,638,537 QoQ
Shares Held
8,162
+5.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.98%
of 13F equity value
Holder Rank
#1,269
of 4,604 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026INTEGRITY ALLIANCE, LLC. holds $34,571,913 across 9 Drug Manufacturers - General names. LLY ranks #1 (28.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
8,162 | $9,789,748 | |
| 2 | JNJ |
Johnson & Johnson
|
30,960 | $7,862,911 | |
| 3 | ABBV |
AbbVie Inc.
|
24,957 | $6,280,179 | |
| 4 | AMGN |
Amgen Inc
|
10,500 | $3,802,260 | |
| 5 | PFE |
Pfizer Inc
|
112,680 | $2,713,334 | |
| 6 | MRK |
Merck & Co., Inc.
|
15,024 | $1,930,584 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
21,389 | $1,232,434 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,635 | $585,585 |
All Filings in LLY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,789,748 | 8,162 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $7,151,211 | 7,775 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $8,909,098 | 8,290 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $3,264,877 | 4,279 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,958,316 | 3,795 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $8,512,654 | 10,307 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $828,356 | 1,073 | Shares | Sole | 2025-05-08 | |
| No filing history on record for this holder in this stock. | ||||||